Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | FDX1 |
| Upstream (Parents) |
|---|
| (<<) MED17 → FDX1 |
| (<<) HAUS2 → FDX1 |
| (<<) HAT1 → FDX1 |
| (<<) LAMP2 → FDX1 |
| (<<) MCTS1 → FDX1 |
| Downstream (Children) |
|---|
| FDX1 → RAB38 (>>) |
| FDX1 → FGFR3 (>>) |
| FDX1 → PYY (>>) |
| FDX1 → FLJ22184 (>>) |
| FDX1 → KIF5C (>>) |
| FDX1 → PDE4B (>>) |
| FDX1 → ACN9 (>>) |
| FDX1 → HOXB2 (>>) |
| FDX1 → LOC645468 (>>) |
| FDX1 → SOAT1 (>>) |
| FDX1 → CEP152 (>>) |
| FDX1 → CPEB3 (>>) |
| FDX1 → LIMCH1 (>>) |
| FDX1 → MED17 (>>) |
| FDX1 → HINFP (>>) |
| FDX1 → GSPT2 (>>) |
| FDX1 → MAN1C1 (>>) |
| FDX1 → CLCN7 (>>) |
| FDX1 → GLRX (>>) |
| FDX1 → HAT1 (>>) |
| FDX1 → DOC2A (>>) |
| FDX1 → TPST2 (>>) |
| FDX1 → TMEM135 (>>) |
| FDX1 → C3orf75 (>>) |
| FDX1 → SLC25A23 (>>) |
